AEON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Aeon Biopharma Inc (AEON) is not a good buy at the moment for a beginner investor with a long-term strategy. The stock lacks strong positive catalysts, has weak financial performance, and no significant trading signals or trends to suggest a promising entry point.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 69.149, and moving averages are converging, showing no clear trend. The stock price is near its resistance level (R1: 1.173), which may limit further upward movement.
NULL identified. No recent news or significant trading trends to act as a catalyst.
Weak financial performance with a significant drop in net income (-26.46% YoY) and EPS (-96.53% YoY). No recent congress trading data or insider/hedge fund activity to suggest confidence in the stock.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped significantly to -$4,538,000 (-26.46% YoY), and EPS fell sharply to -0.39 (-96.53% YoY). Gross margin remained at 0, showing no improvement.
No analyst rating or price target data available.
